Nobuko Ohshima

872 total citations
23 papers, 721 citations indexed

About

Nobuko Ohshima is a scholar working on Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nobuko Ohshima has authored 23 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nobuko Ohshima's work include Influenza Virus Research Studies (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Respiratory viral infections research (5 papers). Nobuko Ohshima is often cited by papers focused on Influenza Virus Research Studies (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Respiratory viral infections research (5 papers). Nobuko Ohshima collaborates with scholars based in Japan, United States and France. Nobuko Ohshima's co-authors include Yoshinobu Okuno, Yoshikazu Kurosawa, Yoshitaka Iba, Fumiko Hirose, Ritsuko Kubota‐Koketsu, Ian A. Wilson, Robyn L. Stanfield, Wenli Yu, Peter S. Lee and Hideki Tanaka and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Nobuko Ohshima

20 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuko Ohshima Japan 13 337 331 153 128 75 23 721
Dicky G. Abraham United States 16 126 0.4× 246 0.7× 59 0.4× 82 0.6× 87 1.2× 20 588
David S. Vallari United States 17 308 0.9× 394 1.2× 81 0.5× 31 0.2× 38 0.5× 22 858
Mostafa Kabiri Germany 9 167 0.5× 213 0.6× 59 0.4× 82 0.6× 22 0.3× 14 543
Anh Tran Canada 13 128 0.4× 225 0.7× 27 0.2× 133 1.0× 184 2.5× 36 573
Yuxiang Huang United States 13 70 0.2× 194 0.6× 82 0.5× 174 1.4× 45 0.6× 18 527
Laura A. Castelli Australia 15 264 0.8× 575 1.7× 16 0.1× 68 0.5× 127 1.7× 24 868
H Y Naim Switzerland 16 162 0.5× 259 0.8× 49 0.3× 92 0.7× 61 0.8× 21 680
Sylvie Chenavas France 7 190 0.6× 248 0.7× 19 0.1× 154 1.2× 70 0.9× 9 450
Irina Zharkikh Russia 10 79 0.2× 168 0.5× 51 0.3× 212 1.7× 121 1.6× 15 494
T. Kuwata Japan 13 93 0.3× 194 0.6× 32 0.2× 231 1.8× 41 0.5× 55 506

Countries citing papers authored by Nobuko Ohshima

Since Specialization
Citations

This map shows the geographic impact of Nobuko Ohshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuko Ohshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuko Ohshima more than expected).

Fields of papers citing papers by Nobuko Ohshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuko Ohshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuko Ohshima. The network helps show where Nobuko Ohshima may publish in the future.

Co-authorship network of co-authors of Nobuko Ohshima

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuko Ohshima. A scholar is included among the top collaborators of Nobuko Ohshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuko Ohshima. Nobuko Ohshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hattori, Yasuhiro, Nobuko Ohshima, Yu Taniguchi, et al.. (2025). 22O Development of anti-CD38-CAR allogeneic γδ T cells as an off-the-shelf use for myeloma. ESMO Open. 10. 104179–104179.
2.
Kubo, Takanori, Seiji Nagano, Takahiko Miyama, et al.. (2023). Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo. Blood. 142(Supplement 1). 3312–3312. 1 indexed citations
3.
Ohshima, Nobuko, Yoshitaka Iba, Ritsuko Kubota‐Koketsu, et al.. (2020). Comprehensive Analysis of Antibodies Induced by Vaccination with 4 Kinds of Avian Influenza H5N1 Pre-Pandemic Vaccines. International Journal of Molecular Sciences. 21(19). 7422–7422.
4.
Ukai, Yoshinori, Yoshitaka Iba, Nobuko Ohshima, et al.. (2018). Isolation of human monoclonal antibodies that bind to two different antigens and are encoded by germline VH and VL genes. Biochemical and Biophysical Research Communications. 503(2). 1141–1147. 1 indexed citations
5.
Hirano, Daisuke, Nobuko Ohshima, Ritsuko Kubota‐Koketsu, et al.. (2018). Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses. Journal of Immunology Research. 2018. 1–15. 10 indexed citations
6.
Lee, Peter S., Nobuko Ohshima, Robyn L. Stanfield, et al.. (2014). Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus. Nature Communications. 5(1). 3614–3614. 166 indexed citations
7.
Ohshima, Nobuko, Ritsuko Kubota‐Koketsu, Yoshitaka Iba, Yoshinobu Okuno, & Yoshikazu Kurosawa. (2014). Two Types of Antibodies Are Induced by Vaccination with A/California/2009pdm Virus: Binding near the Sialic Acid-Binding Pocket and Neutralizing Both H1N1 and H5N1 Viruses. PLoS ONE. 9(2). e87305–e87305. 9 indexed citations
8.
Ohshima, Nobuko, Yoshitaka Iba, Ritsuko Kubota‐Koketsu, et al.. (2011). Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5. Journal of Virology. 85(21). 11048–11057. 93 indexed citations
9.
Okada, Jun, Nobuko Ohshima, Ritsuko Kubota‐Koketsu, et al.. (2010). Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man. Journal of General Virology. 92(2). 326–335. 16 indexed citations
10.
Okada, Jun, Nobuko Ohshima, Ritsuko Kubota‐Koketsu, et al.. (2009). Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968–1973, 1977–1993 and 1997–2003. Virology. 397(2). 322–330. 22 indexed citations
11.
Ohshima, Nobuko, Masahide Takahashi, & Fumiko Hirose. (2003). Identification of a Human Homologue of the DREF Transcription Factor with a Potential Role in Regulation of the Histone H1 Gene. Journal of Biological Chemistry. 278(25). 22928–22938. 58 indexed citations
12.
Kwon, Eun‐Jeong, Hirokazu Seto, Fumiko Hirose, et al.. (2003). Transcription control of a gene for Drosophila transcription factor, DREF by DRE and cis-elements conserved between Drosophila melanogaster and virilis. Gene. 309(2). 101–116. 14 indexed citations
13.
Tanaka, Hideki, et al.. (2003). HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y.. PubMed. 63(20). 6942–7. 59 indexed citations
14.
Hirose, Fumiko, et al.. (2002). Drosophila Mi-2 Negatively Regulates dDREF by Inhibiting Its DNA-Binding Activity. Molecular and Cellular Biology. 22(14). 5182–5193. 41 indexed citations
15.
Hirose, Fumiko, Nobuko Ohshima, Yoshihiro Inoué, et al.. (2001). Ectopic Expression of DREF Induces DNA Synthesis, Apoptosis, and Unusual Morphogenesis in the Drosophila Eye Imaginal Disc: Possible Interaction with Polycomband trithorax Group Proteins. Molecular and Cellular Biology. 21(21). 7231–7242. 72 indexed citations
16.
Tanaka, Hideki, Nobuko Ohshima, & Hiroyoshi Hidaka. (1999). Isolation of cDNAs Encoding Cellular Drug-Binding Proteins Using a Novel Expression Cloning Procedure: Drug-Western. Molecular Pharmacology. 55(2). 356–363. 26 indexed citations
17.
Tanaka, Hideki, Nobuko Ohshima, & Hiroyoshi Hidaka. (1999). Isolation of cDNAs Encoding Cellular Drug-Binding Proteins Using a Novel Expression Cloning Procedure: Drug-Western. Molecular Pharmacology. 55(2). 356–363. 1 indexed citations
18.
Nishitani, Hiroshi, Yoshihiro Yamada, Nobuko Ohshima, Katsuzumi Okumura, & Hiroshi Taguchi. (1995). Identification ofN-(beta-D-Glucopyranosyl)nicotinic Acid as a Major Metabolite from Niacin in Cultured Tobacco Cells. Bioscience Biotechnology and Biochemistry. 59(7). 1336–1338. 8 indexed citations
19.
Uehara, Yoshio, Satoru Takada, Nobuhito Hirawa, et al.. (1994). Vasoconstrictors and Renal Protection Induced by β-Selective Adrenoceptor Antagonist Bisoprolol. Journal of Cardiovascular Pharmacology. 23(6). 897–906. 14 indexed citations
20.
Uehara, Yoshio, Satoru Takada, Yukari Kawabata, et al.. (1994). Antihypertensive Property and Renal Protection by Shichimotsu-koka-to Extract in Salt-induced Hypertension in Dahl Strain Rats. The American Journal of Chinese Medicine. 22(1). 51–62. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dicky G. Abraham Breakdown of academic impact, for papers by David S. Vallari Breakdown of academic impact, for papers by Mostafa Kabiri Breakdown of academic impact, for papers by Anh Tran Breakdown of academic impact, for papers by Yuxiang Huang Breakdown of academic impact, for papers by Laura A. Castelli Breakdown of academic impact, for papers by H Y Naim Breakdown of academic impact, for papers by Sylvie Chenavas Breakdown of academic impact, for papers by Irina Zharkikh Breakdown of academic impact, for papers by T. Kuwata
Rankless by CCL
2026